相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term Survival of Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma A US Population-based Study
Basile Njei
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends
Matthias S. Matter et al.
JOURNAL OF HEPATOLOGY (2014)
Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma - Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience
V. B. Weeda et al.
EUROPEAN JOURNAL OF CANCER (2013)
Akt and mTORC1 Have Different Roles During Liver Tumorigenesis in Mice
Heidi L. Kenerson et al.
GASTROENTEROLOGY (2013)
Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10
Tobias Eggert et al.
GUT (2013)
Prognostic Indicators and Treatment Outcome in 94 Cases of Fibrolamellar Hepatocellular Carcinoma
Ahmed O. Kaseb et al.
ONCOLOGY (2013)
A unifying model for mTORC1-mediated regulation of mRNA translation
Carson C. Thoreen et al.
NATURE (2012)
EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies
Mu-Yan Cai et al.
GUT (2011)
Fibrolamellar carcinomas are positive for CD68
Hillary M. Ross et al.
MODERN PATHOLOGY (2011)
Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation
Stephen C. Ward et al.
MODERN PATHOLOGY (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2008)
Fibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways
Rajesh Kannangai et al.
HUMAN PATHOLOGY (2007)
Outcome of patients with fibrolamellar hepatocellular carcinoma
F Stipa et al.
CANCER (2006)
Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis
XQ Huang et al.
CANCER RESEARCH (2006)
Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis
I Ruvinsky et al.
GENES & DEVELOPMENT (2005)
Hepatocellular carcinoma: Recent trends in the United States
HB El-Serag
GASTROENTEROLOGY (2004)
Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland
BE Welm et al.
JOURNAL OF CELL BIOLOGY (2002)
分享论文
